Site professionnel spécialisé en Rhumatologie
ABSTRACT NUMBER: 0363 Efficacy of Ixekizumab on Disease Activity and Quality of Life in Patients with Active Nonradiographic Axial Spondyloarthritis and Objective Signs of Inflammation, Stratified by Baseline CRP/Sacroiliac Joint…
Uta Kiltz, Jan Brandt-Jürgens, Peter Kästner et al. How Do TNF-alpha-Inhibitors in Medical History Affect Patient Reported Outcomes and Retention in Ankylosing pondylitis Patients Treated with Secukinumab in Real World?…
Baraliakos X, Deodhar A, Dougados M et al. Bimekizumab Long-Term Efficacy and Safety over 96 Weeks in Patients with Ankylosing Spondylitis: Interim Results from a Phase 2b Open-Label Extension Study.…
Deodhar A, Sliwinska-Stanczyk P, Xu H et al. Tofacitinib for the Treatment of Adult Patients with Ankylosing Spondylitis: Primary Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. Numéro d’abstract…
Maksymowych W, Østergaard M, Landewé R et al. Effects of Filgotinib on Spinal Lesions in Patients with Ankylosing Spondylitis: Magnetic Resonance Imaging Data from the Placebo-Controlled, Double‑Blind, Randomized TORTUGA Trial.…
Mark Genovese, Apinya Lertratanakul, Jaclyn K Anderson et al. Efficacy and Safety of Upadacitinib in Patients with Active Psoriatic Arthritis and Inadequate Response to Biologic Disease-Modifying Anti-Rheumatic Drugs: A Double-Blind,…
L’artérite à cellules géantes (ACG) est la vascularite la plus fréquente chez le sujet âgé à partir de 50 ans avec un pic d’incidence entre 70 et 80 ans. L’incidence…
